ERα-positive breast cancer has specific clinicopathological characteristics including a favorable prognosis compared with ERα negative disease, particularly in the first few years following diagnosis [12] and more often low tumor grade in comparison with other breast cancer subtypes [4]. The gene discussed is ESR1; the disease is breast cancer.